1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Night Blindness: new trials by email Literature Review of Night Blindness trials Research Report on Night Blindness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa RNA antisense oligonucleotide for intravitreal injection - Retinitis Pigmentosa, Usher Syndrome Type 2 | Phase 2 | Terminated | Laboratoires Thea | 21 | 2021-09-16 | 2024-08-07 |
Eye Diseases (1) · Genetic Diseases, Inborn (1) · Retinal Diseases (1) · Retinitis Pigmentosa (1) · Usher Syndromes (1) · Vision Disorders (1)
Abnormalities, Multiple (1) · Blindness (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Deaf-Blind Disorders (1) · Deafness (1) · Ear Diseases (1) · Eye Diseases, Hereditary (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Sensorineural (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Otorhinolaryngologic Diseases (1) · Pathological Conditions, Signs and Symptoms (1)
Canada (1) · France (1) · United States (1)